Skip to main content

Table 1 Reactivity of autoimmune patient sera with components of the human exosome

From: Autoantibodies directed to novel components of the PM/Scl complex, the human exosome

Exosome component

IIM [no. (%)]

Myositis/scleroderma overlap syndrome [no. (%)]

Scleroderma [no. (%)]

Total number analyzed

48

10

11

PM/Scl-100a

45 (94)

10 (100)

11 (100)

PM/Scl-75a

26 (54)

9 (90)

7 (64)

hRrp4pb

25 (52)

6 (60)

7 (64)

hRrp40pb

3 (6)

1 (10)

0

hRrp41pb

5 (10)

0

0

hRrp42pb

11 (23)

2 (20)

4 (36)

hRrp46pb

6 (13)

0

0

hCsl4pb

7 (15)

0

0

Total reactivity with novel components

30 (63)

6 (60)

8 (73)

  1. aAnti-PM/Scl-100 and anti-PM/Scl-75 reactivity of IIM sera was previously analyzed [28]. bNovel human exosome components analyzed in this study. IIM = idiopathic inflammatory myopathies; PM/Scl = polymyositis/scleroderma.